{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:07:31Z","timestamp":1758701251675,"version":"3.44.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Atypical Hemolytic Uremic Syndrome (aHUS) is the prototype of renal diseases secondary to dysregulation of the alternative complement pathway. Our previous studies demonstrated that factor I deficiency appears to be common in Tunisian aHUS patients with the recurrence of a rare variant c.1071T&amp;gt;G (p.Ile357Met) localized within exon 10 of the Complement Factor I (<jats:italic>CFI<\/jats:italic>) gene. Data in the literature have demonstrated that this variant has a pathogenic effect affecting factor I synthesis and function. The recurrence of this variant in the Tunisian cohort led us to suggest that it could be characteristic of the Tunisian population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this context, we conducted the current study which included 8 adults and three children with suspected aHUS and decreased factor I levels, as well as one relative. We performed molecular investigation by targeting specifically the p.Ile357Met mutation of the <jats:italic>CFI<\/jats:italic> gene by direct sequencing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and discussion<\/jats:title><jats:p>Interestingly, our results showed that the p.Ile357Met mutation was detected in 3 patients out of 11 (two children and one adult) as well as in one relative. Taking into account the high frequency of this pathogenic variant we could confirm that this latter is a hotspot which could be specific to our population. Thus, it would be interesting to look specifically for this variant in any Tunisian aHUS patient with decreased complement factor I level.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1623432","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T05:34:27Z","timestamp":1755149667000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["High prevalence of the hotspot complement factor I p.Ile357Met pathogenic variant in Tunisian atypical hemolytic uremic syndrome patients: report of three new cases and review of the literature"],"prefix":"10.3389","volume":"16","author":[{"given":"Asma","family":"Tajouri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Ayadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimeh","family":"BenBrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikram","family":"Mami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abir","family":"Boussetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hend","family":"Jlajla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousr","family":"Zerzeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifa","family":"Arbi Sassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamila","family":"Ben Sassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hela","family":"Sahli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Laadhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahar","family":"Gargah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Karim","family":"Zouaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Kallel Sellami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.it.2008.11.003","article-title":"Complement activation and inhibition: a delicate balance","volume":"30","author":"Sj\u00f6berg","year":"2009","journal-title":"Trends Immunol"},{"key":"B2","article-title":"The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation","volume":"21","author":"Lachmann","year":"1975","journal-title":"Clin Exp Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.154.3.856","article-title":"Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3","volume":"154","author":"Pangburn","year":"1981","journal-title":"J Exp Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.060003831.x","article-title":"Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura","volume":"60","author":"Ruggenenti","year":"2001","journal-title":"Kidney Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin Nephrol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-709865","article-title":"and atypical HUS","volume":"129","author":"Jokiranta TS.","year":"2017","journal-title":"Blood."},{"key":"B10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0030041","article-title":"Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome","volume":"3","author":"Zipfel","year":"2007","journal-title":"PloS Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J\u00a0Am Soc Nephrol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2008.064766","article-title":"The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome","volume":"46","author":"Dragon-Durey","year":"2009","journal-title":"J Med Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J Am Soc Nephrol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/CLEP.S245642","article-title":"Epidemiology of atypical hemolytic uremic syndrome: A systematic literature review","volume":"12","author":"Yan","year":"2020","journal-title":"Clin Epidemiol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S245620","article-title":"Atypical hemolytic-uremic syndrome: genetic basis, clinical manifestations, and a multidisciplinary approach to management","volume":"16","author":"Yerigeri","year":"2023","journal-title":"J Multidiscip Healthc."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2018.02.003","article-title":"Atypical hemolytic uremic syndrome","volume":"65","author":"Dixon","year":"2018","journal-title":"Pediatr Clin North Am"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)61076-2","article-title":"Human complement factor I: analysis of cDNA-derived primary structure and assignment of its gene to chromosome 4","volume":"262","author":"Goldberger","year":"1987","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(89)90318-2","article-title":"Mapping of the human complement factor I gene to 4q25","volume":"4","author":"Shiang","year":"1989","journal-title":"Genomics."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1994.1585","article-title":"The organization of the human complement factor I gene (IF): a member of the serine protease gene family","volume":"24","author":"Vyse","year":"1994","journal-title":"Genomics."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20435","article-title":"The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models","volume":"28","author":"Saunders","year":"2007","journal-title":"Hum Mutat"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13217","article-title":"Molecular basis of complement factor I deficiency in Tunisian atypical haemolytic and uraemic syndrome patients","volume":"24","author":"Jlajla","year":"2019","journal-title":"Nephrol (Carlton)."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2023.12.021","article-title":"Hot spot of complement factor I rare variant p.Ile357Met in patients with hemolytic uremic syndrome","volume":"84","author":"Schwotzer","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838702","article-title":"Genetic, molecular and functional analyses of complement factor I deficiency","volume":"39","author":"Nilsson","year":"2009","journal-title":"Eur J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1126\/science.134.3476.380","article-title":"Experimental immunochemistry","volume":"134","author":"Mayer","year":"1961","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J Med Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1279612","article-title":"Functional evaluation of complement factor I variants by immunoassays and SDS-PAGE","volume":"14","author":"Gerogianni","year":"2023","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa114","article-title":"Effect of rare coding variants in the CFI gene on Factor I expression levels","volume":"29","author":"de Jong","year":"2020","journal-title":"Hum Mol Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.866330","article-title":"Complement factor I variants in complement-mediated renal diseases","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddac103","article-title":"Functional analysis of rare genetic variants in complement factor I in advanced age-related macular degeneration","volume":"31","author":"Java","year":"2022","journal-title":"Hum Mol Genet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2640","article-title":"A functional variant in the CFI gene confers a high risk of age-related macular degeneration","volume":"45","author":"van de Ven","year":"2013","journal-title":"Nat Genet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome","volume":"31","author":"Maga","year":"2010","journal-title":"Hum Mutat"},{"key":"B36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1471-2369-13-64","article-title":"Anti-glomerular basement membrane glomerulonephritis and thrombotic microangiopathy in first degree relatives: a case report","volume":"13","author":"Idorn","year":"2012","journal-title":"BMC Nephrol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2011.04.004","article-title":"Complement factor I in health and disease","volume":"48","author":"Nilsson","year":"2011","journal-title":"Mol Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfq010","article-title":"Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS)","volume":"25","author":"Westra","year":"2010","journal-title":"Nephrol Dial Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1623432\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T05:34:28Z","timestamp":1755149668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1623432\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2025.1623432"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1623432","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"article-number":"1623432"}}